Snapchat entices pharmaceutical marketers with its ‘friendlier’ platform
As the social media app aims to grab lucrative drug advertising partnerships, it says users are more open to having intimate health conversations. Yet Snap faces stiff competition.
Snapchat users could soon see more branded content from drug companies looking to tell younger consumers about vaccines, treatments and birth control.
The visual-heavy social media app has been ramping up its pitch to pharmaceutical companies in an effort to grab budget dollars for Snapchat campaigns focused on health and wellness offerings. Snap has not confirmed its advertising aim to reporters, but in February, Snap’s team presented advertising opportunities to drug marketing executives at the DigiPharma Connect Conference.
To make the case, it’s positioning itself as a friendlier social network than Facebook and Twitter, a place where young people feel comfortable discussing private matters and may be more receptive to ads that refer to health matters, according to a slide deck seen by CNBC.
Become a Ragan Insider member to read this article and all other archived content.
Sign up today
Already a member? Log in here.
Learn more about Ragan Insider.
Tags: Snapchat
